Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells
- PMID: 3031657
- PMCID: PMC304546
- DOI: 10.1073/pnas.84.7.1886
Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells
Abstract
Progressive inhibition of tissue factor activity occurs upon its addition to human plasma (serum). This process requires the presence of factor VII(a), facto-X(a), Ca2+, and another component in plasma that we have called the tissue factor inhibitor (TFI). A TFI secreted by HepG2 cells (human hepatoma cell line) was isolated from serum-free conditioned medium in a four-step procedure including CdCl2 precipitation, diisopropylphosphoryl-factor Xa affinity chromatography, Sephadex G-75 superfine gel filtration, and Mono Q ion-exchange chromatography. The purified TFI contained a predominant band at Mr 38,000 on NaDodSO4/polyacrylamide gel electrophoresis that comigrates with inhibitory activity. Like the activity present in plasma, this TFI requires the presence of factor VII(a), factor X(a), and Ca2+ to express inhibitory activity. Its specific activity (assuming an extinction coefficient of 10 at 280 nM, for a 1-cm path length through a 1% solution) was 9800 units/mg of protein, where 1 unit of TFI activity was defined as that present in 1 ml of normal pooled serum.
Similar articles
-
Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.J Biol Chem. 1990 Sep 25;265(27):16096-101. J Biol Chem. 1990. PMID: 2168880
-
A universal lipid exchange protein from rat hepatoma.Eur J Biochem. 1978 Jan 16;82(2):463-71. doi: 10.1111/j.1432-1033.1978.tb12040.x. Eur J Biochem. 1978. PMID: 203454
-
Isolation of the lipoprotein associated coagulation inhibitor produced by HepG2 (human hepatoma) cells using bovine factor Xa affinity chromatography.Thromb Res. 1987 Oct 15;48(2):253-9. doi: 10.1016/0049-3848(87)90422-1. Thromb Res. 1987. PMID: 2827342 No abstract available.
-
Isolation and characterization of a cytosol protein (64/7.2) present in large amounts in rapidly growing hepatomas.Cancer Res. 1978 Jul;38(7):1922-8. Cancer Res. 1978. PMID: 207417
-
Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.Thromb Haemost. 1992 Jul 6;68(1):54-9. Thromb Haemost. 1992. PMID: 1325078
Cited by
-
TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.Blood. 2012 Feb 2;119(5):1256-62. doi: 10.1182/blood-2011-10-388512. Epub 2011 Dec 5. Blood. 2012. PMID: 22144186 Free PMC article.
-
Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure.Front Biosci (Elite Ed). 2012 Jan 1;4(1):392-400. doi: 10.2741/e386. Front Biosci (Elite Ed). 2012. PMID: 22201881 Free PMC article. Review.
-
alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.J Clin Invest. 1994 Feb;93(2):703-10. doi: 10.1172/JCI117023. J Clin Invest. 1994. PMID: 8113404 Free PMC article.
-
Determination of the disulfide bond pairings in human tissue factor pathway inhibitor purified from Escherichia coli.J Protein Chem. 1995 Jul;14(5):341-7. doi: 10.1007/BF01886791. J Protein Chem. 1995. PMID: 8590602
-
Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus.Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):704-11. doi: 10.1161/ATVBAHA.111.243733. Epub 2012 Jan 5. Arterioscler Thromb Vasc Biol. 2012. PMID: 22223730 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous